Metformin withdrawal study for metabolic syndrome
Part of Hormones & metabolism clinical trials.
This study looks at what happens when people with metabolic syndrome temporarily stop taking metformin. It aims to understand how their bodies respond when the medication is paused for 14 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been taking metformin for at least one year as part of your regular care.
- You have metabolic syndrome, which means you have at least three of the following: large waist size, high triglycerides, low HDL cholesterol, high blood pressure, or high blood sugar.
- Your metformin dose has been stable for the last 3 months.
- You are willing to stop metformin for 14 days if you are in the group that stops.
- You agree to several tests, including glucose drinks, blood draws, and wearing a continuous glucose monitor.
- Your kidney function must be good, and you must not have serious diabetes complications like eye or kidney damage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests a personalized program called PRISM to help improve how your body responds to insulin. If you have metabolic syndrome (a cluster of conditions like large waist size, high blood pressure, or high blood sugar) and insulin resistance, the study will use a continuous glucose monitor, smart ring, and food logging app to give you tailored feedback.
This study compares a new liquid version of metformin to the usual tablet form to see if the liquid is absorbed differently. Healthy volunteers take both forms in a controlled setting.
This trial tests a liquid form of metformin to see how well people tolerate it compared to regular tablets. It may help if you are generally healthy and interested in an easier-to-swallow option.
This study tests if combining intermittent fasting, calorie reduction, and physical activity can help manage metabolic syndrome (a group of risk factors that increase your chance of heart disease, stroke, and diabetes). If you have at least three of five specific health issues (like belly fat, high blood pressure, or high blood sugar) and are an adult aged 18 or older, you may be able to join.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests if a treatment called MD helps people with metabolic syndrome, a group of conditions like high blood pressure, high blood sugar, abnormal cholesterol, and excess belly fat. You may join if you have at least three of these issues.
Hear when a new Metabolic Syndrome (MetS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.